Cargando…
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
Pulmonary arterial hypertension, a disease largely neglected until a few decades ago, is presently the object of intense studies by several research teams. Despite considerable progress, pulmonary arterial hypertension remains a major clinical problem, because it is not always easy to diagnose, trea...
Autores principales: | Correale, Michele, Ferraretti, Armando, Monaco, Ilenia, Grazioli, Davide, Di Biase, Matteo, Brunetti, Natale Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174907/ https://www.ncbi.nlm.nih.gov/pubmed/30323613 http://dx.doi.org/10.2147/VHRM.S133921 |
Ejemplares similares
-
Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2019) -
Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization
por: Correale, Michele, et al.
Publicado: (2020) -
Where Do We Stand?
Publicado: (1891) -
Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016) -
Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)